Division of Pediatric Pulmonology and Intensive Care, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Division of Pediatric Critical Care, Department of Pediatrics, PGIMER, Chandigarh, India.
Crit Care Med. 2023 Nov 1;51(11):1449-1460. doi: 10.1097/CCM.0000000000005952. Epub 2023 Jun 9.
To determine if initial fluid resuscitation with balanced crystalloid (e.g., multiple electrolytes solution [MES]) or 0.9% saline adversely affects kidney function in children with septic shock.
Parallel-group, blinded multicenter trial.
PICUs of four tertiary care centers in India from 2017 to 2020.
Children up to 15 years of age with septic shock.
Children were randomized to receive fluid boluses of either MES (PlasmaLyte A) or 0.9% saline at the time of identification of shock. All children were managed as per standard protocols and monitored until discharge/death. The primary outcome was new and/or progressive acute kidney injury (AKI), at any time within the first 7 days of fluid resuscitation. Key secondary outcomes included hyperchloremia, any adverse event (AE), at 24, 48, and 72 hours, and all-cause ICU mortality.
MES solution ( n = 351) versus 0.9% saline ( n = 357) for bolus fluid resuscitation during the first 7 days.
The median age was 5 years (interquartile range, 1.3-9); 302 (43%) were girls. The relative risk (RR) for meeting the criteria for new and/or progressive AKI was 0.62 (95% CI, 0.49-0.80; p < 0.001), favoring the MES (21%) versus the saline (33%) group. The proportions of children with hyperchloremia were lower in the MES versus the saline group at 24, 48, and 72 hours. There was no difference in the ICU mortality (33% in the MES vs 34% in the saline group). There was no difference with regard to infusion-related AEs such as fever, thrombophlebitis, or fluid overload between the groups.
Among children presenting with septic shock, fluid resuscitation with MES (balanced crystalloid) as compared with 0.9% saline resulted in a significantly lower incidence of new and/or progressive AKI during the first 7 days of hospitalization.
确定在脓毒性休克患儿中,最初使用平衡晶体液(例如,多种电解质溶液[MES])或 0.9%生理盐水进行液体复苏是否会对肾功能产生不利影响。
平行分组、盲法、多中心试验。
2017 年至 2020 年期间,印度四家三级护理中心的 PICUs。
年龄在 15 岁以下的脓毒性休克患儿。
患儿在确定休克时随机接受 MES(PlasmaLyte A)或 0.9%生理盐水的液体冲击。所有患儿均按照标准方案进行治疗,并监测至出院/死亡。主要结局为在液体复苏后的前 7 天内任何时间发生的新的和/或进行性急性肾损伤(AKI)。关键次要结局包括在 24、48 和 72 小时时的高氯血症、任何不良事件(AE)以及 ICU 全因死亡率。
在第 1 天内,MES 溶液(n = 351)与 0.9%生理盐水(n = 357)用于冲击液复苏。
中位年龄为 5 岁(四分位距,1.3-9);302 例(43%)为女孩。符合新的和/或进行性 AKI 标准的相对风险(RR)为 0.62(95%CI,0.49-0.80;p < 0.001),MES(21%)组优于生理盐水(33%)组。MES 组在 24、48 和 72 小时时高氯血症的患儿比例低于生理盐水组。MES 组和生理盐水组 ICU 死亡率无差异(MES 组 33%,生理盐水组 34%)。两组之间在与输注相关的 AE 方面没有差异,如发热、血栓性静脉炎或液体过载。
在出现脓毒性休克的患儿中,与 0.9%生理盐水相比,用 MES(平衡晶体液)进行液体复苏在住院的前 7 天内可显著降低新的和/或进行性 AKI 的发生率。